Free Trial
NASDAQ:ORGS

Orgenesis (ORGS) Stock Price, News & Analysis

Orgenesis logo
$1.00 +0.98 (+4,445.45%)
As of 08/1/2025 11:00 AM Eastern

About Orgenesis Stock (NASDAQ:ORGS)

Key Stats

Today's Range
$0.02
$1.00
50-Day Range
$0.00
$2.27
52-Week Range
$0.00
$10.80
Volume
1,114 shs
Average Volume
7,917 shs
Market Capitalization
$4.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Orgenesis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

ORGS MarketRank™: 

Orgenesis scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Orgenesis.

  • Percentage of Shares Shorted

    0.17% of the outstanding shares of Orgenesis have been sold short.
  • Short Interest Ratio / Days to Cover

    Orgenesis has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Orgenesis has recently increased by 42.11%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Orgenesis does not currently pay a dividend.

  • Dividend Growth

    Orgenesis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.17% of the outstanding shares of Orgenesis have been sold short.
  • Short Interest Ratio / Days to Cover

    Orgenesis has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Orgenesis has recently increased by 42.11%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Orgenesis this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for ORGS on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Orgenesis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.66% of the stock of Orgenesis is held by insiders.

  • Percentage Held by Institutions

    Only 22.56% of the stock of Orgenesis is held by institutions.

  • Read more about Orgenesis' insider trading history.
Receive ORGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter.

ORGS Stock News Headlines

Orgenesis (NASDAQ:ORGS) Stock Price Up 899,900% - What's Next?
Orgenesis Delays Filing of Quarterly Report
This Crypto Is Set to Explode in January
Free summit reveals where Bitcoin goes after $120k Don't miss this rare opportunity to learn directly from the experts who are driving this market…
Orgenesis secures $5M equity investment from Williamsburg Venture
Orgenesis Inc. Reports Q3 2024 Financial Results
See More Headlines

ORGS Stock Analysis - Frequently Asked Questions

Orgenesis' stock was trading at $1.89 at the start of the year. Since then, ORGS stock has decreased by 47.1% and is now trading at $1.00.

Orgenesis Inc. (NASDAQ:ORGS) issued its quarterly earnings results on Friday, August, 11th. The company reported ($1.50) EPS for the quarter, missing analysts' consensus estimates of $0.60 by $2.10. The business had revenue of $6.98 million for the quarter.

Orgenesis shares reverse split before market open on Wednesday, September 25th 2024.The 1-10 reverse split was announced on Monday, September 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, September 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Orgenesis subsidiaries include Koligo Therapeutics, and Tamir Biotechnology Inc.

Shares of ORGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Orgenesis investors own include NVIDIA (NVDA), Energy Transfer (ET), BioLineRx (BLRX), Pfizer (PFE), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE) and Enbridge (ENB).

Company Calendar

Last Earnings
8/11/2023
Today
8/02/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ORGS
CIK
1460602
Fax
N/A
Employees
150
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.36 million
Net Margins
-3,827.81%
Pretax Margin
-3,931.93%
Return on Equity
N/A
Return on Assets
-130.18%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.07

Sales & Book Value

Annual Sales
$662 thousand
Price / Sales
7.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($6.58) per share
Price / Book
-0.15

Miscellaneous

Outstanding Shares
4,799,000
Free Float
4,527,000
Market Cap
$4.80 million
Optionable
No Data
Beta
0.47

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ORGS) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners